Patents by Inventor Govind Kapadia

Govind Kapadia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6267946
    Abstract: A method of reducing the percentage of Epstein-Barr virus genome-carrying cells which exhibit Epstein-Barr virus early antigen induction, wherein the Epstein-Barr virus genome-carrying cells have been cultivated in the presence of a tumor-promoting chemical and/or a tumor-inducing chemical. The method is performed by: a) cultivating Epstein-Barr virus genome-carrying cells in the presence of a tumor-promoting chemical and/or a tumor-inducing chemical; and b) treating the Epstein-Barr virus genome-carrying cells with a synthetic anthraquinone colorant containing a sulfonated phenylamino group. The colorant is effective to reduce the incidence of Epstein-Barr virus early antigen induction in the cultivated Epstein-Barr virus genome-carrying cells.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: July 31, 2001
    Inventor: Govind Kapadia
  • Patent number: 6228365
    Abstract: A method of reducing the incidence of pulmonary tumor formation in animals exposed to a tumor-promoting chemical or a tumor initiating by providing a group of animals which have been exposed to a tumor-promoting chemical or a tumor-initiating chemical with drinking water containing betanins. Preferably, the betanins are obtained from a beetroot extract.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: May 8, 2001
    Inventor: Govind Kapadia
  • Patent number: 6225296
    Abstract: A method of inhibiting Epstein-Barr virus early antigen induction in Epstein-Barr virus genome-carrying cells which have been cultivated in vitro in a medium containing at least one chemical selected from the group consisting of tumor-inducing chemicals and tumor promoting chemicals by adding an effective amount of a synthetic colorant to the medium, wherein the synthetic colorant is an aromatic azo dye.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: May 1, 2001
    Inventor: Govind Kapadia
  • Patent number: 6080411
    Abstract: A method of reducing the incidence of splenomegalia induced by ultra violet radiation in mammals by exposing a group of test mammals to intense ultraviolet radiation, where the exposure is repeated at regular intervals over a test period such that the cumulative radiation exposure per mammal is sufficient to cause an increase in an average spleen size in a group of unprotected mammals; and administering drinking water containing a defined concentration of betanins to the group of test mammals during the test period, said defined concentration being sufficient to prevent such an increase in average spleen size.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: June 27, 2000
    Inventor: Govind Kapadia